✦ LIBER ✦

Locoregional Recurrence and Survival Outcomes by Type of Local Therapy and Trastuzumab Use Among Women with Node-Negative, HER2-Positive Breast Cancer

✍ Scribed by Peterson, David J.; Truong, Pauline T.; Sadek, Betro T.; Alexander, Cheryl S.; Wiksyk, Bradley; Shenouda, Mina; Raad, Rita Abi; Taghian, Alphonse G.

Book ID: 125406122
Publisher: Springer
Year: 2014
Tongue: English
Weight: 268 KB
Volume: 21
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-014-3767-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High recurrence risk and use of adjuvant

High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers

✍ Akiyo Horio; Takashi Fujita; Hironori Hayashi; Masaya Hattori; Naoto Kondou; Mai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 505 KB

Comparison of overall survival between t

Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancer

✍ Yan-Xia Shi; Yu-Ting Tan; Zhong-Yu Yuan; Shu-Sen Wang; Rou-Jun Peng; Xin An; Ye 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 345 KB

Sequential administration of dose-dense

Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

✍ Yago Nieto; José Manuel Aramendía; Jaime Espinós; Susana De la Cruz; Oscar Ferná 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 337 KB

Use of adjuvant trastuzumab in women wit

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network

✍ Rachel A. Freedman; Melissa E. Hughes; Rebecca A. Ottesen; Jane C. Weeks; Yulei 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

2–47 Low Locoregional Recurrence Rate Am

2–47 Low Locoregional Recurrence Rate Among Node-Negative Breast Cancer Patients With Tumors 5 cm or Larger Treated by Mastectomy, With or Without Adjuvant Systemic Therapy and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials

✍ Moran, M.S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Clinical outcomes in patients who receiv

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

✍ Kaplan, Muhammet Ali; Isikdogan, Abdurrahman; Koca, Doğan; Kucukoner, Mehmet; Gu 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 245 KB